Loengard Anna U
SEC insider (Form 3/4/5 filer). CIK 0001952723. Director at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 6, 2026. Located in WILMINGTON, DE.
Companies Loengard Anna U has filed insider reports for
- CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV): Director
Loengard Anna U
CIK: 0001952723
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 6, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
AwardDirect79.4K shares- - Aug 13, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PurchaseIndirect12K shares at avg. $2.60$31K - Aug 13, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
PurchaseIndirect14.5K shares at avg. $2.59$38K - Jan 6, 2025CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
AwardDirect61K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 6, 2026 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Award | 79,365 | - | $0 | Direct |
| Aug 13, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Purchase | 12,000 | $2.60 | $31,200 | Indirect |
| Aug 13, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Purchase | 14,500 | $2.59 | $37,555 | Indirect |
| Jan 6, 2025 | CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | Award | 60,975 | - | $0 | Direct |
1-4 of 4 transactions